VALIDATION OF THE REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM AND TRANSPLANTATION RISK INDEX ON POSTTRANSPLANTATION OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

被引:0
|
作者
Yahng, S. [1 ]
Jeon, Y. W. [2 ]
Yoon, J. H. [2 ]
Shin, S. H. [3 ]
Lee, S. E. [2 ]
Choi, Y. S. [4 ]
Kim, D. Y. [4 ]
Lee, J. H. [4 ]
Eom, K. S. [2 ]
Lee, S. [2 ]
Min, C. K. [2 ]
Kim, H. J. [2 ]
Lee, J. W. [2 ]
Lee, K. H. [4 ]
Min, W. S. [2 ]
Lee, J. H. [4 ]
Kim, Y. J. [2 ]
机构
[1] Catholic Univ Korea, Incheon St Marys Hosp, Hematol, Inchon, South Korea
[2] Catholic Univ Korea, Hematol, Catholic Blood & Marrow Transplantat Ctr, Seoul St Marys Hosp, Seoul, South Korea
[3] Catholic Univ Korea, Yeoido St Marys Hosp, Hematol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Hematol, Seoul, South Korea
关键词
D O I
10.1016/S0145-2126(15)30260-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
259
引用
收藏
页码:S129 / S130
页数:3
相关论文
共 50 条
  • [41] The Revised International Prognostic Scoring System (IPSS-R) Is Not Predictive Of Survival In Patients With Secondary Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Mukherjee, Sudipto
    Tiu, Ramon V.
    Saunthararajah, Yogen
    Keng, Michael K.
    Seastone, David J.
    Hobson, Sean
    Advani, Anjali S.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2013, 122 (21)
  • [42] Utility Of Revised International Prognostic Scoring System (R-IPSS) To Predict Outcome Of Myelodysplastic Syndromes (MDS) Patients After Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
    Corrales-Yepez, Maria Gabriela
    Field, Teresa
    List, Alan
    Anasetti, Claudio
    Perkins, Janelle
    Al Ali, Najla H.
    Mishra, Asmita
    Padron, Eric
    Lancet, Jeffrey E.
    Kharfan-Dabaja, Mohamed A.
    Komrokji, Rami S.
    BLOOD, 2013, 122 (21)
  • [43] Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes (vol 141, pg 1768, 2023)
    Kewan, T.
    Bahaj, W.
    Durmaz, A.
    BLOOD, 2024, 143 (18) : 1879 - 1879
  • [44] Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes
    Alkharabsheh, Omar
    Saadeh, Salwa S.
    Patnaik, Mrinal S.
    Alkhateeb, Hassan
    Gangat, Naseema
    Begna, Kebede H.
    Hogan, William J.
    Greipp, Patricia T.
    He, Rong
    Nguyen, Phuong L.
    Litzow, Mark R.
    Al-Kali, Aref
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : E398 - E401
  • [45] Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms
    Yang, Tingting
    Jiang, Binqian
    Luo, Yi
    Zhao, Yanmin
    Ouyang, Guifang
    Yu, Jian
    Lan, Jianping
    Lu, Ying
    Lai, Xiaoyu
    Ye, Baodong
    Chen, Yi
    Liu, Lizhen
    Xu, Yang
    Shi, Pengfei
    Xiao, Haowen
    Hu, Huixian
    Guo, Qunyi
    Fu, Huarui
    Ye, Yishan
    Wang, Xinyu
    Sun, Jie
    Zheng, Weiyan
    He, Jingsong
    Zhao, Yi
    Wu, Wenjun
    Cai, Zhen
    Wei, Guoqing
    Huang, He
    Shi, Jimin
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (12) : E391 - E394
  • [46] External validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic syndromes
    Chernak, Brian
    Ali, Abdullah
    Jan, Amna
    Mukherjee, Sanjay
    Jurcic, Joseph G.
    Raza, Azra
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry
    Kawabata, Hiroshi
    Tohyama, Kaoru
    Matsuda, Akira
    Araseki, Kayano
    Hata, Tomoko
    Suzuki, Takahiro
    Kayano, Hidekazu
    Shimbo, Kei
    Zaike, Yuji
    Usuki, Kensuke
    Chiba, Shigeru
    Ishikawa, Takayuki
    Arima, Nobuyoshi
    Nogawa, Masaharu
    Ohta, Akiko
    Miyazaki, Yasushi
    Mitani, Kinuko
    Ozawa, Keiya
    Arai, Shunya
    Kurokawa, Mineo
    Takaori-Kondo, Akifumi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (03) : 375 - 384
  • [48] Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry
    Hiroshi Kawabata
    Kaoru Tohyama
    Akira Matsuda
    Kayano Araseki
    Tomoko Hata
    Takahiro Suzuki
    Hidekazu Kayano
    Kei Shimbo
    Yuji Zaike
    Kensuke Usuki
    Shigeru Chiba
    Takayuki Ishikawa
    Nobuyoshi Arima
    Masaharu Nogawa
    Akiko Ohta
    Yasushi Miyazaki
    Kinuko Mitani
    Keiya Ozawa
    Shunya Arai
    Mineo Kurokawa
    Akifumi Takaori-Kondo
    International Journal of Hematology, 2017, 106 : 375 - 384
  • [49] International prognostic scoring system and other prognostic systems for myelodysplastic syndromes - Response
    Greenberg, P
    Cox, C
    Bennett, J
    BLOOD, 1997, 90 (10) : 4233 - 4234
  • [50] Impact of the revised International Prognostic Scoring System on the outcome of patients with acute myeloid leukemia with or without antecedent myelodysplastic syndrome
    F Stölzel
    M Kramer
    B Mohr
    M Wermke
    M Bornhäuser
    G Ehninger
    M Schaich
    U Platzbecker
    Leukemia, 2014, 28 : 723 - 725